Expertise as a service, delivered hands-on.
We provide expertise as a service across the full journey from early innovation to commercialisation — working with your team, not in a deck. What we are known for, and what we bring alongside it.
Commercialisation & market access
A strategic path you can act on — where the product fits, who pays for it, and what has to happen in what order. Built from having taken products to market ourselves, not from a framework.
- Commercialisation
- Market access
- Growth
- Structure & frameworks
Hands-on execution & interim resources
Senior capability inside your team for a defined stretch, running commercialisation, market access, regulatory and funding workstreams through to completion. Not a plan and a handover — we will stay until it is done, without you adding a permanent hire.
- Delivery
- Project management
- Funding & regulatory
- Interim resource
Corporate finance & deals
Terms you can still live with two years later. Deal structuring, negotiation and financing from people who have raised the capital and then had to operate under the terms.
- Deal structuring
- Financing
- IP strategy
Board & governance
Independent judgement in the room when the decision is difficult — Chair and non-executive director capability, plus the governance discipline a growing company needs in place before an investor asks for it.
- Board advisory
- Chair / NED
- Governance
Due diligence & investment assessment
A clear view before you commit. Commercial, financial and technical due diligence on early-stage technology — what the asset is, what it still needs, and what would stop us from investing our own money.
- Commercial & financial DD
- Technical & IP review
- Investment assessment
Building a business takes more than money.
We understand that high-growth businesses don’t always have unlimited cash. For selected opportunities, Keyflexion can structure engagements using a combination of fees and equity. By investing our expertise alongside founders, we align our interests with yours and share in the long-term value we help create.
The plan matters more than what you can pay today.
Judgement you can only get from having done it.
Each of us works across more than one discipline, so you get a single joined-up answer rather than a separate opinion from each specialism.
Not deal advisers looking in — a managing director who raised the money, a CFO who prepared the business for sale. We know what the terms mean once you have to live with them.
We translate strong science into commercial outcomes and get the best from a technology.
No standard playbook. We work out what is actually blocking you — the science, the structure, the capital or the market — and start there.
Grants, approvals, reimbursement coding, laboratory accreditation, market entry — we have taken products through each of these, not advised on them from outside.
Between us we have built businesses, partnerships and distribution across Australia, the US, Europe and Asia — relationships that open doors, not a directory of contacts.
No set formula; every engagement is shaped around the organisation, its market and its stage.
We bring the structure and framework early-stage companies are missing: the right milestones, in the right order, and the discipline to reach them.
Discounted, deferred or equity-based arrangements, so senior help is available while cash is tight.